Baylor Scott and White Medical Center
Baylor Scott and White Medical Center
Temple, Texas, United States4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-10-05 | NCT06982521 | |
| A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis | Moderately to Severely Active Ulcerative Colitis | Active, not recruiting | Phase 3 | 2026-10-02 | NCT06588855 | |
| A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease | Moderately to Severely Active Crohns Disease | Recruiting | Phase 3 | 2026-09-16 | NCT06819878 | |
| Insignia™ Hip Stem Outcomes Study | Femoral Fractures, Hip Injuries, Leg Injuries, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Trochanteric Fractures, arthritic joint disease, arthropathy, autoimmune disease, avascular necrosis, bone disorder, bone fracture, connective tissue disorder, femoral neck fracture, hip fracture, immune system disorder, injury, musculoskeletal system disorder, osteoarthritis, osteoarthritis, hip, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not applicable | 2026-05-18 | NCT05144191 |